CytoDyn Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Inventories, net (Tables)

Inventories, net (Tables)

9 Months Ended

12 Months Ended

Feb. 28, 2023

May 31, 2022

Inventories, net

Summary of Inventories, net of reserves

Inventories were as follows (in thousands):


		February 28, 2023			May 31, 2022
Raw materials		$	—		$	16,264
Work-in-progress			—			1,665
Total inventories, net		$	—		$	17,929


		As of May 31,
(in thousands)		2022			2021
Raw materials		$	16,264		$	28,085
Work-in-progress			1,665			65,394
Total inventories, net		$	17,929		$	93,479

Schedule of remaining shelf life of inventory

				Raw Materials										Work-in-progress
(in thousands, Expiration period ending May 31, )		Remaining shelf-life (mos)		Specialized			Resins		Other		Total Raw Materials			Bulk drug product			Finished drug product			Total inventories
2023		0 to 12		$	3,658		—		1,421		$	5,079		$	1,824		$	—		$	6,903
2024		13 to 24			682		16,264		1,590			18,536			1,665			—			20,201
2025		25 to 36			2,099		—		—			2,099			—			29,142			31,241
2026		37 to 48			731		—		—			731			—			32,344			33,075
Thereafter		49 or more			—		—		—			—			—			—			—
Inventories, gross					7,170		16,264		3,011			26,445			3,489			61,486			91,420
Write-off					(7,170)		—		(3,011)			(10,181)			(1,824)			(61,486)			(73,491)
Inventories, net				$	—		16,264		—		$	16,264		$	1,665		$	—		$	17,929